CAPTRUST Financial Advisors
ICCC icon

CAPTRUST Financial Advisors’s ImmuCell ICCC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed -$2K – 2986
2022
Q2 		$2K Sell
200
-1,000
-83% -$8.67K ﹤0.01% 4468
2022
Q1 		$12K Buy
1,200
+1,000
+500% +$8.63K ﹤0.01% 3703
2021
Q4 		$2K Hold
200
– – ﹤0.01% 4412
2021
Q3 		$2K Hold
200
– – ﹤0.01% 4264
2021
Q2 		$2K Hold
200
– – ﹤0.01% 4175
2021
Q1 		$2K Hold
200
– – ﹤0.01% 4046
2020
Q4 		$1K Hold
200
– – ﹤0.01% 3260
2020
Q3 		$1K Hold
200
– – ﹤0.01% 2904
2020
Q2 		$1K Buy
+200
New +$872 ﹤0.01% 2707

Other funds holding ICCC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

CAPTRUST Financial Advisors's ICCC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ImmuCell (ICCC) in Q3 2022, closing a stake of 200 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in ICCC in Q2 2020 and held it in 9 quarters. The position peaked at $12K in Q1 2022. 26 funds tracked by Wall St. Rank hold ICCC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining ImmuCell position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 200 ImmuCell shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in ImmuCell in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's ImmuCell position peaked at $12K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held ImmuCell as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.